Gerald S. Lazarus

9.7k total citations · 2 hit papers
148 papers, 7.6k citations indexed

About

Gerald S. Lazarus is a scholar working on Molecular Biology, Cell Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Gerald S. Lazarus has authored 148 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 33 papers in Cell Biology and 29 papers in Pathology and Forensic Medicine. Recurrent topics in Gerald S. Lazarus's work include Protease and Inhibitor Mechanisms (26 papers), Autoimmune Bullous Skin Diseases (24 papers) and Wound Healing and Treatments (23 papers). Gerald S. Lazarus is often cited by papers focused on Protease and Inhibitor Mechanisms (26 papers), Autoimmune Bullous Skin Diseases (24 papers) and Wound Healing and Treatments (23 papers). Gerald S. Lazarus collaborates with scholars based in United States, Japan and Germany. Gerald S. Lazarus's co-authors include Norman M. Schechter, Harold M. Fullmer, Pamela J. Jensen, A. John Barrett, David J. Margolis, John R. Daniels, Mary C. Burleigh, Robert S. Brown, Jonathan M. Zenilman and Margaret A. Fonder and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Gerald S. Lazarus

146 papers receiving 7.0k citations

Hit Papers

Definitions and Guideline... 1994 2026 2004 2015 1994 2008 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Gerald S. Lazarus 1.8k 1.7k 1.4k 996 940 148 7.6k
Lillian B. Nanney 2.0k 1.1× 2.3k 1.4× 1.1k 0.8× 338 0.3× 1.8k 1.9× 172 8.5k
Robert F. Diegelmann 3.6k 2.0× 2.0k 1.2× 538 0.4× 297 0.3× 2.3k 2.4× 152 9.7k
Ulpu Saarialho‐Kere 1.4k 0.8× 3.5k 2.1× 1.4k 1.0× 472 0.5× 1.1k 1.2× 141 10.8k
A H Kang 563 0.3× 2.7k 1.6× 2.1k 1.5× 548 0.6× 831 0.9× 109 10.6k
Joost Schalkwijk 996 0.5× 3.3k 2.0× 2.6k 1.8× 332 0.3× 956 1.0× 259 11.2k
Howard G. Welgus 1.0k 0.6× 3.7k 2.2× 1.9k 1.4× 449 0.5× 1.5k 1.6× 130 14.3k
Mona Ståhle 1.4k 0.8× 2.7k 1.6× 4.0k 2.9× 438 0.4× 475 0.5× 125 8.9k
Cord Sunderkötter 589 0.3× 3.7k 2.2× 4.2k 3.0× 710 0.7× 801 0.9× 239 11.4k
Matthias Goebeler 683 0.4× 4.1k 2.5× 4.0k 2.9× 1.5k 1.5× 862 0.9× 306 12.0k
Dana T. Graves 1.2k 0.6× 7.6k 4.6× 4.0k 2.9× 500 0.5× 2.0k 2.1× 239 20.7k

Countries citing papers authored by Gerald S. Lazarus

Since Specialization
Citations

This map shows the geographic impact of Gerald S. Lazarus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald S. Lazarus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald S. Lazarus more than expected).

Fields of papers citing papers by Gerald S. Lazarus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald S. Lazarus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald S. Lazarus. The network helps show where Gerald S. Lazarus may publish in the future.

Co-authorship network of co-authors of Gerald S. Lazarus

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald S. Lazarus. A scholar is included among the top collaborators of Gerald S. Lazarus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald S. Lazarus. Gerald S. Lazarus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soetikno, Vivian, et al.. (2020). Alpha-Mangostin Improves Cardiac Hypertrophy and Fibrosis and Associated Biochemical Parameters in High-Fat/High-Glucose Diet and Low-Dose Streptozotocin Injection-Induced Type 2 Diabetic Rats. SHILAP Revista de lepidopterología. 1 indexed citations
2.
Ammons, Mary Cloud B., Brian Tripet, James T. Van Leuven, et al.. (2015). Biochemical Association of Metabolic Profile and Microbiome in Chronic Pressure Ulcer Wounds. PLoS ONE. 10(5). e0126735–e0126735. 42 indexed citations
3.
Malas, Mahmoud B., Umair Qazi, Gerald S. Lazarus, et al.. (2013). Comparative effectiveness of surgical interventions aimed at treating underlying venous pathology in patients with chronic venous ulcer. Journal of Vascular Surgery Venous and Lymphatic Disorders. 2(2). 212–225. 8 indexed citations
4.
Selvin, Elizabeth, et al.. (2011). Hemoglobin A1c Predicts Healing Rate in Diabetic Wounds. Journal of Investigative Dermatology. 131(10). 2121–2127. 156 indexed citations
5.
Melendez, Johan H., et al.. (2009). Real-Time PCR Assays compared to Culture-Based Approaches for Identification of Aerobic Bacteria in Chronic Wounds. Clinical Microbiology and Infection. 3 indexed citations
6.
Lazarus, Gerald S.. (2006). Irwin Freedberg: “Grandpa” to Generations of Dermatologists. Journal of Investigative Dermatology. 126(3). 520–521. 1 indexed citations
7.
Morrow, Jason D., et al.. (1999). Increased Formation of ThromboxaneIn Vivo in Humans with Mastocytosis. Journal of Investigative Dermatology. 113(1). 93–97. 13 indexed citations
8.
Spiers, Elizabeth M., Gerald S. Lazarus, & Bernadette Lyons-Giordano. (1996). EXPRESSION OF PLASMINOGEN ACTIVATORS IN BASAL CELL CARCINOMA. The Journal of Pathology. 178(3). 290–296. 14 indexed citations
9.
Miller, Stanley J., Pamela J. Jensen, LEONARD M. DZUBOW, & Gerald S. Lazarus. (1992). Urokinase Plasminogen Activator Is Immunocytochemically Detectable in Squamous Cell but Not Basal Cell Carcinomas. Journal of Investigative Dermatology. 98(3). 351–358. 18 indexed citations
10.
Margolis, David J., et al.. (1992). Alterations in renal function in psoriasis patients treated with cyclosporin, 5 mg/kg/day. Journal of the American Academy of Dermatology. 26(2). 195–197. 11 indexed citations
11.
Mizutani, Hitoshi, Norman M. Schechter, Gerald S. Lazarus, Roy A. Black, & Thomas S. Kupper. (1991). Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase.. The Journal of Experimental Medicine. 174(4). 821–825. 269 indexed citations
12.
Lazarus, Gerald S., et al.. (1985). The biological role of proteinases and their inhibitors in skin. 24 indexed citations
13.
Choi, John & Gerald S. Lazarus. (1985). Immunofluorescent localization of the human skin chymotrypsin-like proteinase to skin mast cells. Federation Proceedings. 44(4). 1 indexed citations
14.
Briggaman, Robert A., Norman M. Schechter, J Fräki, & Gerald S. Lazarus. (1984). Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes.. The Journal of Experimental Medicine. 160(4). 1027–1042. 160 indexed citations
16.
Fräki, Jorma E., Robert A. Briggaman, & Gerald S. Lazarus. (1983). Transplantation of Psoriatic Skin onto Nude Mice. Journal of Investigative Dermatology. 80(1). S31–S35. 30 indexed citations
17.
Lazarus, Gerald S., Lowell A. Goldsmith, & Michael D. Tharp. (1979). Diagnosis of skin disease. 4 indexed citations
18.
Lazarus, Gerald S. & Charlotte Thomas. (1978). Chemotactic proteinase induces polymorphonuclear leukocyte accumulation in psoriasis. Journal of Investigative Dermatology. 71(4). 1 indexed citations
19.
Lazarus, Gerald S., et al.. (1977). [Heart rate of anaesthesiologists under physical and psychological professional stress (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26(8). 375–80. 4 indexed citations
20.
Dingle, J. T., A. Robin Poole, Gerald S. Lazarus, & A. John Barrett. (1973). IMMUNOINHIBITION OF INTRACELLULAR PROTEIN DIGESTION IN MACROPHAGES. The Journal of Experimental Medicine. 137(5). 1124–1141. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026